U.S. Indices Started Cautiously But Ended The Day With NASDAQ, S&P 500 At New Highs

Wall Street ended higher on Tuesday after a hesitant start to the day with the Nasdaq and S&P 500 indexes hitting fresh all-time highs. The alarming estimates of the outbreak in the United States were trumped by expectations of coronavirus vaccination. Despite reluctance in Congress, in the United States, markets continue to focus on a new support plan. Investors are looking forward to Japan’s launch of a $700 billion stimulus package, and hope the ECB will announce on Thursday that its asset buyback programs will be enhanced and expanded to resolve the Covid-19 crisis.


5 Stocks to make up the PERFECT 2021 gold portfolio

Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.

Click here to download your free report right away

Sponsored


At the close, the Dow Jones rose 0.35 percent to 30,173 points close to its Friday peak of 30,218 points), while the large S&P 500 index advanced 0.28 percent to 3,702 points to a new milestone, and the technology-rich and biotech-rich Nasdaq Composite index added 0.50 percent to 12,582 points, setting its fourth consecutive record.

On the market side, after the announcement of a planned $5 billion capital increase, Tesla Inc yo-yoed before finishing up 1.27 percent. Pfizer gained 3.2 percent in the race for the anti-Covid-19 vaccine as the FDA is expected to approve its vaccine on Thursday, and Johnson and Johnson took 1.7 percent after saying that the results of their anti-Covid vaccine’s Phase 3 trial will be released at the end of January.

As for AstraZeneca (up 0.85%), an overall efficacy of 70.4 percent (62 percent for the first protocol, and 90 percent for the second) of its vaccine was confirmed on Tuesday. AstraZeneca has started to send data for rapid approval to regulators around the world, said Pascal Soriot, the Anglo-Swedish group’s CEO.

Moderna also benefitted for being in the race for vaccine, adding 6.48 percent to its value on Tuesday. The company has also reported a 90 percent efficacy of vaccine against Covid-19.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Lloyd Martinez
I am resigned and living in South Florida. I delighted in a fruitful and fluctuated vocation as a writer, business financier, venture broker, city treasurer, speculation counselor, NASD mediator, specialist, and tenured college educator. My scholarly accreditations incorporate having earned an experts degree in Economics and a doctorate certificate in Finance.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Velodyne Lidar Inc. (VLDR): Continues Bringing Light To Investors Everywhere

The laser radar manufacturer, Velodyne Lidar (VLDR), announced that it had received a multi-year contract. Sales of the company are expected to grow significantly...

Private Investors Pumped GameStop (GME) Stock Up

Shares of GameStop Corp (GME) video games grew by 144.8 percent, to $159.18, backed by mid-session trade. In contrast, the company's shares were worth...

Related Articles

Velodyne Lidar Inc. (VLDR): Continues Bringing Light To Investors Everywhere

The laser radar manufacturer, Velodyne Lidar (VLDR), announced that it had received a multi-year contract. Sales of the company are expected to grow significantly...

Private Investors Pumped GameStop (GME) Stock Up

Shares of GameStop Corp (GME) video games grew by 144.8 percent, to $159.18, backed by mid-session trade. In contrast, the company's shares were worth...

DDOG Stock: Datadog Inc (DDOG) Is Still Worth a Bite

Since the start of the year, Datadog Inc. (NASDAQ: DDOG) shares have soared by 150%. Many citations confirm the company's position as one of...

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.